Evaluation of Visual Training System in Patients With Glaucoma
Launched by ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY · May 22, 2024
Trial Information
Current as of February 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Glaucoma is a chronic eye disease that causes irreversible damage to the optic nerve and can lead to severe vision loss and blindness. In China, the blindness rate among glaucoma patients is 22.7%, accounting for 8.8% of the total blind population. Among individuals aged 40 and above in urban and rural areas of China, approximately 9.2 million suffer from glaucoma, with 55% experiencing blindness in at least one eye and 18.1% experiencing blindness in both eyes \[1,2\]. Glaucoma patients may experience severe impairment in visual function, leading to significant limitations in vision-relate...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age ≥ 10 years old
- • 2. diagnosed with primary glaucoma or developmental glaucoma
- • 3. the best corrected visual acuity ≥0.1 and the mean deviation of the visual field worse or equal to -6 dB
- • 4. visual acuity, intraocular pressure, and other eye conditions have been stable for more than 3 months
- • 5. participants capable of understanding the purpose of the study and providing informed consent
- • 6. participants capable of cooperating with relevant examinations.
- Exclusion Criteria:
- • 1. a history of eye surgery or eye laser within three months
- • 2. complicated with other ophthalmopathy affecting visual function (except cataract, ametropia), such as age-related macular degeneration, diabetic retinopathy, optic nerve disease, retinal vascular disease, etc.
- • 3. serious systemic diseases, such as neurological diseases, cardiovascular diseases, psychological diseases, malignant tumors, etc
- • 4. pregnant or lactating women.
About Zhongshan Ophthalmic Center, Sun Yat Sen University
The Zhongshan Ophthalmic Center, affiliated with Sun Yat-sen University, is a leading institution in ophthalmic research and clinical care in China. Renowned for its commitment to advancing the field of ophthalmology, the center specializes in innovative treatments and technologies for various eye conditions. With a strong emphasis on clinical trials, the center aims to enhance patient outcomes through rigorous scientific investigation and collaboration with global research networks. Its multidisciplinary team of experts is dedicated to fostering cutting-edge research that translates into effective therapeutic strategies for vision preservation and restoration.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0